Credit Suisse’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $266M | Sell |
1,916,217
-42,104
| -2% | -$5.29M | 0.25% | 67 |
|
|
2023
Q4 | $243M | Sell |
1,958,321
-374,414
| -16% | -$38.3M | 0.23% | 75 |
|
|
2023
Q3 | $218M | Buy |
2,332,735
+316,324
| +16% | +$35.7M | 0.22% | 83 |
|
|
2023
Q2 | $259M | Sell |
2,016,411
-284,342
| -12% | -$34.4M | 0.26% | 68 |
|
|
2023
Q1 | $267M | Sell |
2,300,753
-227,660
| -9% | -$25.5M | 0.27% | 64 |
|
|
2022
Q4 | $286M | Sell |
2,528,413
-491,429
| -16% | -$54M | 0.3% | 62 |
|
|
2022
Q3 | $243M | Buy |
3,019,842
+44,655
| +2% | +$3.78M | 0.27% | 64 |
|
|
2022
Q2 | $222M | Buy |
2,975,187
+127,183
| +4% | +$11.6M | 0.23% | 71 |
|
|
2022
Q1 | $364M | Sell |
2,848,004
-152,476
| -5% | -$16.7M | 0.31% | 57 |
|
|
2021
Q4 | $403M | Sell |
3,000,480
-1,012,196
| -25% | -$145M | 0.21% | 71 |
|
|
2021
Q3 | $549M | Sell |
4,012,676
-1,025,516
| -20% | -$129M | 0.3% | 50 |
|
|
2021
Q2 | $538M | Sell |
5,038,192
-223,284
| -4% | -$21.4M | 0.29% | 52 |
|
|
2021
Q1 | $473M | Buy |
5,261,476
+528,788
| +11% | +$49.6M | 0.24% | 66 |
|
|
2020
Q4 | $437M | Buy |
4,732,688
+1,616,336
| +52% | +$144M | 0.21% | 89 |
|
|
2020
Q3 | $321M | Buy |
3,116,352
+442,408
| +17% | +$46.2M | 0.2% | 93 |
|
|
2020
Q2 | $271M | Sell |
2,673,944
-282,668
| -10% | -$25.3M | 0.19% | 98 |
|
|
2020
Q1 | $199M | Sell |
2,956,612
-174,572
| -6% | -$10.9M | 0.17% | 115 |
|
|
2019
Q4 | $171M | Sell |
3,131,184
-814,288
| -21% | -$38.6M | 0.12% | 149 |
|
|
2019
Q3 | $147M | Sell |
3,945,472
-599,124
| -13% | -$23.3M | 0.12% | 145 |
|
|
2019
Q2 | $170M | Buy |
4,544,596
+71,508
| +2% | +$2.25M | 0.15% | 121 |
|
|
2019
Q1 | $133M | Sell |
4,473,088
-746,008
| -14% | -$26.2M | 0.12% | 149 |
|
|
2018
Q4 | $156M | Buy |
5,219,096
+1,003,320
| +24% | +$31.8M | 0.16% | 112 |
|
|
2018
Q3 | $151M | Sell |
4,215,776
-290,552
| -6% | -$9.01M | 0.14% | 135 |
|
|
2018
Q2 | $107M | Sell |
4,506,328
-2,973,260
| -40% | -$63M | 0.11% | 177 |
|
|
2018
Q1 | $139M | Buy |
7,479,588
+1,695,200
| +29% | +$25.1M | 0.13% | 139 |
|
|
2017
Q4 | $83M | Buy |
5,784,388
+1,795,660
| +45% | +$23.3M | 0.07% | 270 |
|
|
2017
Q3 | $48.8M | Buy |
3,988,728
+1,416,032
| +55% | +$25M | 0.05% | 427 |
|
|
2017
Q2 | $47M | Buy |
2,572,696
+1,364,176
| +113% | +$25.2M | 0.05% | 429 |
|
|
2017
Q1 | $25.6M | Buy |
1,208,520
+3,164
| +0.3% | +$61.8K | 0.02% | 703 |
|
|
2016
Q4 | $18M | Buy |
1,205,356
+791,536
| +191% | +$14M | 0.02% | 877 |
|
|
2016
Q3 | $9.07M | Buy |
413,820
+199,468
| +93% | +$4.44M | 0.01% | 1267 |
|
|
2016
Q2 | $4.25M | Sell |
214,352
-76,812
| -26% | -$1.31M | ﹤0.01% | 1754 |
|
|
2016
Q1 | $4.94M | Buy |
291,164
+105,624
| +57% | +$1.76M | 0.01% | 1538 |
|
|
2015
Q4 | $3.8M | Sell |
185,540
-26,408
| -12% | -$549K | ﹤0.01% | 1803 |
|
|
2015
Q3 | $4.55M | Sell |
211,948
-79,536
| -27% | -$1.77M | 0.01% | 1631 |
|
|
2015
Q2 | $5.83M | Buy |
291,484
+127,292
| +78% | +$2.24M | 0.01% | 1611 |
|
|
2015
Q1 | $2.56M | Sell |
164,192
-104,940
| -39% | -$1.59M | ﹤0.01% | 2190 |
|
|
2014
Q4 | $3.7M | Buy |
269,132
+154,636
| +135% | +$1.89M | ﹤0.01% | 2013 |
|
|
2014
Q3 | $1.14M | Sell |
114,496
-471,296
| -80% | -$4.82M | ﹤0.01% | 2937 |
|
|
2014
Q2 | $5.81M | Buy |
585,792
+161,864
| +38% | +$1.43M | ﹤0.01% | 1826 |
|
|
2014
Q1 | $4.38M | Buy |
423,928
+136,676
| +48% | +$1.41M | ﹤0.01% | 1865 |
|
|
2013
Q4 | $2.54M | Buy |
287,252
+65,380
| +29% | +$517K | ﹤0.01% | 2445 |
|
|
2013
Q3 | $1.56M | Buy |
221,872
+67,164
| +43% | +$426K | ﹤0.01% | 2608 |
|
|
2013
Q2 | $868K | Buy |
+154,708
| New | +$741K | ﹤0.01% | 2898 |
|
Other funds holding DXCM
N
Credit Suisse's DXCM Position: Q1 2024 in Review
Credit Suisse reduced its DexCom (DXCM) stake by 2.2% in Q1 2024, selling an estimated $5.29M and leaving 1,916,217 shares worth $266M. The position accounts for 0.25% of the portfolio, ranked #67.
Credit Suisse first reported a position in DXCM in Q2 2013 and has held it in 44 quarters since. The position peaked at $549M in Q3 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.
- Credit Suisse held 1,916,217 shares of DexCom worth $266M as of Q1 2024.
- Credit Suisse sold 42,104 DexCom shares in Q1 2024, an estimated $5.29M.
- DexCom made up 0.25% of Credit Suisse's portfolio in Q1 2024, its #67 holding.
- Credit Suisse first reported a position in DexCom in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's DexCom position peaked at $549M in Q3 2021.
- 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.